Guerbet Investor Relations Material
Latest events
H2 2023
Guerbet
Q2 2025 TU
24 Jul, 2025
Q1 2025 TU
24 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Guerbet SA
Access all reports
Guerbet SA is a France-based healthcare company specializing in the development, manufacture, and distribution of diagnostic imaging products, particularly contrast agents used in medical imaging. Guerbet offers a comprehensive range of imaging solutions for Computed Tomography (CT)/Cath Lab examinations, Magnetic Resonance Imaging (MRI), and interventional imaging. Their product lineup includes iodinated active ingredients for CT/Cath Lab contrast agents and gadolinium complexes for MRI. The company is headquartered in Villepinte, France, and its shares are listed on the Euronext Paris.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
GBT
Country
🇫🇷 France